Survival outcomes in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer: Does the indication for neoadjuvant chemotherapy matter?
1. 系统已在2025-11-06 11:17:04对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.ygyno.2025.10.002
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0090825825010182
其他信息:
出版社: Elsevier BV
作者: Sarah Andres; Andrew Tannous; Ryan M. Kahn; Effi Yeoshoua; Qin Zhou; Alexia Iasonos; Nadeem R. Abu-Rustum; Ahmed Al-Niaimi; Vance Broach; Ginger J. Gardner; Yukio Sonoda; Oliver Zivanovic; Dennis S. Chi; Kara C. Long

